Answer
Ciprofloxacin, a CYP1A2 inhibitor, increased rasagiline exposure (AUC) by 83% when co-administered with rasagiline hemitartrate, so this combination requires caution.
Sources for this answer
- Rasagiline KRKA 1mgKrka UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked